Menu
GeneBe

KLK2

kallikrein related peptidase 2, the group of Kallikreins

Basic information

Region (hg38): 19:50861567-50880567

Links

ENSG00000167751NCBI:3817OMIM:147960HGNC:6363Uniprot:P20151AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the KLK2 gene.

  • Inborn genetic diseases (10 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLK2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
8
clinvar
2
clinvar
10
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 8 2 0

Variants in KLK2

This is a list of pathogenic ClinVar variants found in the KLK2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
19-50874745-G-A not specified Uncertain significance (Jan 10, 2023)2460837
19-50874773-G-T not specified Uncertain significance (Aug 12, 2021)2243657
19-50874775-A-G not specified Uncertain significance (Dec 08, 2023)3115845
19-50874819-C-A not specified Uncertain significance (Aug 08, 2023)2617489
19-50874837-G-C not specified Uncertain significance (Nov 10, 2022)2325744
19-50876491-G-A not specified Uncertain significance (Oct 10, 2023)3115846
19-50876557-C-T not specified Uncertain significance (Oct 27, 2022)2211324
19-50876576-G-A not specified Uncertain significance (Nov 09, 2023)3115847
19-50876589-T-A not specified Uncertain significance (Apr 17, 2023)2568904
19-50876878-G-A not specified Uncertain significance (Jul 13, 2021)2353243
19-50876884-G-A not specified Likely benign (Dec 20, 2021)2212057
19-50876916-T-C not specified Likely benign (Aug 04, 2023)2616227
19-50876920-A-G not specified Uncertain significance (Dec 03, 2021)2379342
19-50878425-G-A not specified Likely benign (Mar 12, 2024)3115848
19-50878491-C-T not specified Uncertain significance (Nov 08, 2022)3115849
19-50878508-G-C not specified Uncertain significance (Dec 15, 2023)3115850
19-50878521-C-T Acute myeloid leukemia Pathogenic (-)2573115

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
KLK2protein_codingprotein_codingENST00000325321 519000
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0001280.6451256990481257470.000191
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.1171431470.9730.000007471690
Missense in Polyphen4249.2890.85212612
Synonymous0.7625057.30.8720.00000295527
Loss of Function0.78279.620.7284.10e-7111

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00005800.0000580
Ashkenazi Jewish0.000.00
East Asian0.0007640.000761
Finnish0.00004620.0000462
European (Non-Finnish)0.0002470.000246
Middle Eastern0.0007640.000761
South Asian0.00006550.0000653
Other0.0003260.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin.;
Pathway
Renin-angiotensin system - Homo sapiens (human);Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human);Androgen Receptor Network in Prostate Cancer;Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;Signal Transduction;Metabolism of proteins;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs);Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3;RHO GTPases activate PKNs;RHO GTPase Effectors;Signaling by Rho GTPases;Coregulation of Androgen receptor activity;Degradation of the extracellular matrix;Regulation of Androgen receptor activity (Consensus)

Intolerance Scores

loftool
0.281
rvis_EVS
0.55
rvis_percentile_EVS
81.48

Haploinsufficiency Scores

pHI
0.0786
hipred
N
hipred_score
0.166
ghis
0.436

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0320

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Gene ontology

Biological process
regulation of systemic arterial blood pressure;extracellular matrix disassembly;zymogen activation
Cellular component
extracellular region;secretory granule;extracellular exosome
Molecular function
serine-type endopeptidase activity